DUPIXENT MYWAY
Live / Registered — Registered — Section 8 accepted (as of 20 Dec 2023)
What this means for you
Registered since 10 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87208922
- Registration number
- 5308193
- Mark type
- Design + words
- Filed
- 19 Oct 2016
- Published for opposition
- 21 Mar 2017
- Registered
- 10 Oct 2017
- Attorney of record
- Karen Lim
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing medical information and medical treatment support programs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Owner
- Sanofi Biotechnology, Gentilly, FR
- Sanofi Biotechnology, Paris, FR
- Sanofi Biotechnology, Paris, FR
Prosecution history
- 20 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 20 Dec 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 20 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Sept 2023 — TEAS SECTION 8 RECEIVED
- 10 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 06 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Aug 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jul 2017 — USE AMENDMENT FILED
- 18 Aug 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
- 16 May 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT